Novavax, Inc. (NVAX) Reports In-Line Q2 EPS
Tweet
Share
E-mailGet Alerts NVAX Hot Sheet
Price: $10.26 +0.39%
Financial Fact:
Basic and diluted net loss per share: -0.24
Today's EPS Names:
VIVO, BIOX, PMCB, More
Financial Fact:
Basic and diluted net loss per share: -0.24
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Novavax, Inc. (NASDAQ: NVAX) reported Q2 EPS of ($0.05), in-line with the analyst estimate of ($0.05). Revenue for the quarter came in at $7.1 million versus the consensus estimate of $6.68 million.
For earnings history and earnings-related data on Novavax, Inc. (NVAX) click here.
For earnings history and earnings-related data on Novavax, Inc. (NVAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Activist investor presses Xerox to review financial services arm - Bloomberg
- ASP Isotopes Hosts Inaugural Capital Markets Day and Provides Operational Update
- JPMorgan starts FedEx Freight at Overweight on post-spin turnaround
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
